Clinical Trial Update: Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients [Phase 3]

View source ↗

Summary

This document reports an extension study of tocilizumab for long-term treatment of moderate-to-severe rheumatoid arthritis, with the trial status listed as comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Chugai Pharma Taiwan | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED